BMSSC
TMO icon

B. Metzler seel. Sohn & Co’s Thermo Fisher Scientific TMO Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228M Sell
454,402
-126,888
-22% -$60.9M 1.97% 12
2026
Q1 		$286M Sell
581,290
-6,060
-1% -$3.29M 2.65% 8
2025
Q4 		$341M Sell
587,350
-29,151
-5% -$16.5M 2.97% 7
2025
Q3 		$299M Buy
616,501
+2,776
+0.5% +$1.29M 2.64% 7
2025
Q2 		$249M Buy
613,725
+22,657
+4% +$9.47M 2.38% 10
2025
Q1 		$294M Buy
591,068
+185,870
+46% +$101M 3.03% 8
2024
Q4 		$211M Sell
405,198
-6,092
-1% -$3.35M 2.17% 10
2024
Q3 		$254M Buy
411,290
+61,816
+18% +$36.6M 2.53% 10
2024
Q2 		$193M Sell
349,474
-5,374
-2% -$3.08M 1.87% 11
2024
Q1 		$204M Buy
354,848
+3,981
+1% +$2.23M 2.26% 10
2023
Q4 		$186M Sell
350,867
-5,674
-2% -$2.75M 2.38% 8
2023
Q3 		$180M Buy
356,541
+5,783
+2% +$3.08M 2.72% 8
2023
Q2 		$183M Buy
350,758
+18,800
+6% +$10.1M 2.48% 8
2023
Q1 		$190M Buy
331,958
+6,286
+2% +$3.54M 2.95% 8
2022
Q4 		$179M Buy
325,672
+13,988
+4% +$7.41M 3.06% 7
2022
Q3 		$158M Buy
311,684
+286
+0.1% +$160K 2.87% 8
2022
Q2 		$169M Sell
311,398
-434,597
-58% -$239M 2.78% 8
2022
Q1 		$176M Buy
745,995
+452,044
+154% +$260M 2.36% 8
2021
Q4 		$196M Buy
293,951
+224,241
+322% +$140M 2.55% 7
2021
Q3 		$39.8M Sell
69,710
-2,989
-4% -$1.64M 0.58% 30
2021
Q2 		$36.7M Buy
72,699
+8,944
+14% +$4.22M 0.55% 32
2021
Q1 		$29.1M Sell
63,755
-3,393
-5% -$1.62M 0.48% 33
2020
Q4 		$31.9M Buy
+67,148
New +$31.5M 0.59% 27

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

B. Metzler seel. Sohn & Co's TMO Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co reduced its Thermo Fisher Scientific (TMO) stake by 22% in Q2 2026, selling an estimated $60.9M and leaving 454,402 shares worth $228M. The position accounts for 1.97% of the portfolio, ranked #12.

B. Metzler seel. Sohn & Co first reported a position in TMO in Q4 2020 and has held it in 23 quarters since. The position peaked at $341M in Q4 2025. 2,624 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 454,402 shares of Thermo Fisher Scientific worth $228M as of Q2 2026.
  • B. Metzler seel. Sohn & Co sold 126,888 Thermo Fisher Scientific shares in Q2 2026, an estimated $60.9M.
  • Thermo Fisher Scientific made up 1.97% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #12 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 23 quarters since.
  • B. Metzler seel. Sohn & Co's Thermo Fisher Scientific position peaked at $341M in Q4 2025.
  • 2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.